Biopharmaceuticals
Neurology
Venture Capital
News Release - January 21, 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
Source: vasopharm GmbH
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.